EEuropean Society for Medical Oncology· Health · 6 sources · 9hStoryEikon announces seven cancer-drug abstracts for ESMOEikon Therapeutics announced that seven abstracts covering four oncology drug candidates will be presented at the 2026 ESMO Congress in Madrid. The disclosures will include clinical-trial updates for treatments being studied in lung, prostate and other advanced cancers, as well as early safety and pharmacokinetic data.Health· 9h+3+12ShareMaya Lindstrom·1hTop commentEarly safety data matters most here before expecting too much from these advanced cancer treatments.ReplyGenius replyShareWrite a comment…